Results 131 to 140 of about 61,970 (240)

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Multidrug-resistant tuberculosis.

open access: yesAnnals of the Academy of Medicine, Singapore, 1995
In 1993, the World Health Organization declared tuberculosis a global emergency. Tuberculosis is the leading cause of death attributable to a single infectious pathogen. One-third of the world's population are at risk of developing the disease. In countries confronted with the human immunodeficiency virus (HIV) epidemic, the overlap of these two ...
S K, Lee   +3 more
openaire   +1 more source

Point of care tests for tuberculosis (TB) : economic analysis report [PDF]

open access: yes
A number of clinical/disease areas have been prioritised by the TSB and DH for the DIIA Innovation Platform. To support commissioning of technology developments in the area of tuberculosis detection in humans, a scoping review has been undertaken to help
Szczepura, Ala, Osipenko, Leeza
core  

Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia

open access: yes, 2017
Demelash Assefa,1 Berhanu Seyoum,2 Lemessa Oljira2 1KNCV Tuberculosis Foundation, Addis Ababa, 2School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia Abstract: Multidrug-resistant tuberculosis (MDR-TB) has ...
Assefa D, Seyoum B, Oljira L
core  

Mutational Insights into GyrA and GyrB Genes in Mycobacterium tuberculosis: A Genetic Basis for Fluoroquinolone Resistance in Multidrug-resistant Tuberculosis

open access: yes
The global tuberculosis (TB) epidemic is becoming progressively more complex due to the increasing prevalence of multidrug-resistant TB (MDR-TB), particularly with resistance to fluoroquinolones (FQs).
Mo Ahamad Khan   +4 more
core   +1 more source

XDR TB [PDF]

open access: yes
Extensively drug resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or

core  

Home - About - Disclaimer - Privacy